METHOD FOR TREATMENT OF ENDOMETRIOSIS AND PREVENTION OF ITS RELAPSES Russian patent published in 2022 - IPC A61K31/404 A61K38/21 A61K38/19 A61K38/14 A61P35/00 

FIELD: health care.

SUBSTANCE: invention relates to health care, in particular to gynecology, and concerns the treatment of endometriosis and the prevention of its relapses. The method includes complex therapy for 6 months by daily oral administration of indinol-forto 1 capsule 200 mg 2 times a day, monthly injection of human recombinant interferon gamma with an activity of 500,000 IU 5 injections every other day and injection of tumor necrosis factor thymosin alpha 1 with an activity of 100,000 IU 5 injections every other day. The injections of human recombinant interferon gamma and tumor necrosis factor - thymosin alpha 1 recombinant are administered alternately every 24 hours. If necessary, an additional course of complex therapy is carried out for 2 weeks before surgery, including daily oral administration of indinol-vorto 1 capsule 200 mg 2 times a day, injection of human recombinant interferon gamma with an activity of 500,000 IU 5 injections every other day and injection of tumor necrosis factor thymosin alpha with an activity of 100,000 IU 5 injections every other day, injections of human recombinant interferon gamma and tumor necrosis factor - thymosin alpha 1 recombinant are administered alternately every 24 hours.

EFFECT: invention enables to reduce the risk of relapses and preserve childbearing function due to a synergistic complex of drugs with a prolonged multidirectional multitargeted pharmacological effect that ensures tissue regeneration and the formation of a normal tissue structure without the stage of necrosis of endometrioid foci and the development of fibrosis.

2 cl, 2 ex